We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $145B
1-Year Est. Return 34.61%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
+17.21%
1 Year Est. Return
+34.61%
3 Year Est. Return
+158.21%
5 Year Est. Return
+226.99%
10 Year Est. Return
+1,390.17%
AUM
$122B
AUM Growth
+$12.9B
Cap. Flow
-$2.37B
Cap. Flow %
-1.95%
Top 10 Hldgs %
42.22%
Holding
644
New
63
Increased
244
Reduced
244
Closed
80

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.26B
2
TMUS icon
T-Mobile US
TMUS
+$1.04B
3
SLB icon
SLB Ltd
SLB
+$936M
4
TMO icon
Thermo Fisher Scientific
TMO
+$858M
5
TEAM icon
Atlassian
TEAM
+$781M

Sector Composition

Rank Sector Weight
1 Technology 38.75%
2 Consumer Discretionary 19.8%
3 Healthcare 13.64%
4 Financials 8.74%
5 Communication Services 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
326
United Parcel Service
UPS
$88.6B
$19.1M 0.02%
106,768
-15,052
-12% -$2.67M
FIVN icon
327
FIVE9
FIVN
$2.11B
$18.6M 0.02%
225,216
-72,370
-24% -$4.86M
CBAY
328
DELISTED
Cymabay Therapeutics
CBAY
$18.3M 0.02%
1,671,532
+1,047,869
+168% +$9.76M
LW icon
329
Lamb Weston
LW
$7.22B
$18.1M 0.01%
157,781
-111,970
-42% -$12.5M
AVTR icon
330
Avantor
AVTR
$9.32B
$18.1M 0.01%
882,122
+351,282
+66% +$7.1M
KNTK icon
331
Kinetik
KNTK
$3.72B
$17.6M 0.01%
500,977
+85,894
+21% +$2.73M
FIBK icon
332
First Interstate BancSystem
FIBK
$3.69B
$17.6M 0.01%
+737,735
New +$18.6M
SILK
333
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$17.4M 0.01%
536,864
-360,092
-40% -$13.1M
WAL icon
334
Western Alliance Bancorporation
WAL
$8.79B
$16.9M 0.01%
+462,349
New +$16M
ATVI
335
DELISTED
Activision Blizzard
ATVI
$16.8M 0.01%
199,519
-1,917
-1% -$155K
SEDG icon
336
SolarEdge
SEDG
$2.51B
$16.7M 0.01%
62,024
-66
-0.1% -$18.9K
GPCR icon
337
Structure Therapeutics
GPCR
$3.41B
$16.6M 0.01%
399,780
HLNE icon
338
Hamilton Lane
HLNE
$4.91B
$16.6M 0.01%
207,448
-42,210
-17% -$3.03M
OM icon
339
Outset Medical
OM
$84.7M
$16.4M 0.01%
49,974
+9,519
+24% +$2.9M
CUZ icon
340
Cousins Properties
CUZ
$5.19B
$16.2M 0.01%
709,937
+52,857
+8% +$1.11M
SRPT icon
341
Sarepta Therapeutics
SRPT
$1.57B
$15.7M 0.01%
137,240
+16,979
+14% +$2.19M
HRT
342
DELISTED
HireRight Holdings Corporation
HRT
$15.6M 0.01%
1,383,518
+105,265
+8% +$1.1M
BLFS icon
343
BioLife Solutions
BLFS
$1.53B
$15.6M 0.01%
706,120
-219,261
-24% -$4.62M
AES icon
344
AES
AES
$10.5B
$15.5M 0.01%
749,618
-2,165,230
-74% -$47.7M
BCE icon
345
BCE
BCE
$20.2B
$15.5M 0.01%
340,459
-1,472
-0.4% -$68.5K
BMRN icon
346
BioMarin Pharmaceuticals
BMRN
$11.6B
$15.4M 0.01%
177,801
-496,307
-74% -$46.7M
QTWO icon
347
Q2 Holdings
QTWO
$3.8B
$15.3M 0.01%
495,327
-2,436
-0.5% -$63.9K
CABA icon
348
Cabaletta Bio
CABA
$437M
$15.2M 0.01%
1,180,564
+400,000
+51% +$4.34M
PBA icon
349
Pembina Pipeline
PBA
$28.4B
$15.1M 0.01%
480,319
-181,823
-27% -$5.81M
IART icon
350
Integra LifeSciences
IART
$1.29B
$15.1M 0.01%
366,844
+6,758
+2% +$325K

Similar funds

Jennison Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Jennison Associates held 644 positions worth $122B, up 12% from $109B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Jennison Associates's Q2 2023 filing shows 63 new, 244 increased, 244 reduced and 80 closed positions. Its largest new stake was ServiceNow: 10,029,285 shares worth $1.13B. The largest sale was Danaher, an estimated $1.26B.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Jennison Associates's largest Q2 2023 buy was ServiceNow: 10,029,285 shares worth $1.13B.
  • Jennison Associates added most to Advanced Micro Devices in Q2 2023, an estimated $969M increase.
  • Jennison Associates's biggest Q2 2023 reduction was Danaher, cutting an estimated $1.26B.
  • Jennison Associates fully exited Northrop Grumman in Q2 2023, selling an estimated $279M.
  • Jennison Associates's ten largest holdings make up 42% of its $122B portfolio in Q2 2023.
  • Jennison Associates opened 63 new positions and closed 80 in Q2 2023.
  • Jennison Associates's portfolio value rose 12% quarter-over-quarter to $122B.

Based on Jennison Associates's 13F filing for Q2 2023, filed 3 Aug 2023.